Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2004

View Archived Issues

PSK-3471: a novel SERM prevents bone loss and restores bone mass in rodents/News in Context

Seliciclib induces apoptosis in multiple myeloma cell lines

Alfimeprase shows efficacy in the treatment of occluded CVADs

Aerosolized Radilex superior to muscle injection following radiation exposure

AVI BioPharma updates NeuGene antisense program progress

Helicon launches phase I studies of IPL-455903

PLX-647 selected for development for inflammatory diseases

Recordati to develop silodosin for BPH in Europe

Equetro approved for bipolar disorder

HuMax-CD20 IND accepted for phase I/II study in RA

ExonHit synthesizes small molecule in Allergan collaboration

FoldRx completes Series A financing

ViRexx and AltaRex shareholders vote in favor of acquisition

KetoCytonyx completes phase I study of KTX-0101

R-207910: a novel diarylquinolone for the treatment of tuberculosis

TASQ enters clinical studies in prostate cancer patients

ZymoGenetics updates pipeline progress

Pfizer issues Bextra safety warnings

Commercial launch for Evoclin

Financing at NeoTropiX

Natural product boosts proteoglycan synthesis in chondrocytes via upregulation of TGF-beta2

PPARalpha and gamma agonists for prevention and treatment of atherosclerosis

GCS-100 induces apoptosis through different pathways in MM and B-cell lymphoma/leukemia cells

Update on the antitumor effects of forodesine in hematological malignancies

Antibacterial pleuromutilin derivatives claimed by GlaxoSmithKline

New dopamine D3 receptor ligands in early development at Abbott

A series of analgesic agents prepared and tested by Boehringer Ingelheim

Novel MMP-3 inhibitors described in patent literature

Scientists at Maruha report Edg receptor antagonists

A series of spiropiperidine derivatives presented by Merck & Co.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...